Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Pristiq® (Desvenlafaxine) Extended-Release Tablets in Generalized Social Anxiety Disorder

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01316302
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:24.328374+00:00
Published At
2014-10-08T00:00:00+00:00
Record Updated At
2016-10-17
Results Posted At
2014-10-08
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Social Anxiety Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-10-17"
protocolSection.identificationModule.nctId
"NCT01316302"
protocolSection.identificationModule.officialTitle
"A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Pristiq\u00ae (Desvenlafaxine) Extended-Release Tablets in Generalized Social Anxiety Disorder"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-10-08"

Study condition terms

  • Social Anxiety Disorder (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.